BACKGROUND: Liver vitamin A (VA) concentration is the gold standard for VA status, but is not routinely accessible. Adipose tissue VA concentrations, as retinol and retinyl esters, may be correlated to liver VA. α-VA (as α-retinol) is a cleavage product of α-carotene that traces postprandial VA distribution to tissues but cannot recirculate from hepatic stores, providing insight into tissue VA sources. OBJECTIVE: We performed a secondary analysis of VA and α-VA in Mongolian gerbil liver and adipose to determine the suitability of adipose tissue VA as a biomarker of VA status. METHODS: Gerbils (n = 186) consumed feeds containing 0-15.9 μg (0-55.6 nmol) retinol activity equivalents/g as preformed VA and/or provitamin A carotenoids for 36-62 d in 3 studies. Body fat percentage was determined in the final study by MRI. Serum and liver retinol, α-retinol, and retinyl esters were extracted and analyzed by HPLC or ultra-performance LC (UPLC). Epididymal and retroperitoneal adipose tissue retinol and α-retinol were determined by UPLC after homogenization, saponification, and extraction. Linear regression models with appropriate data transformations identified determinants of adipose VA concentrations. RESULTS: Liver VA did not predict serum retinol concentrations. After logarithmic transformation of adipose and liver values, liver VA positively predicted both adipose depots' VA concentrations (P < 0.001, R 2 > 0.7). Adding serum retinol or body fat percentage did not significantly increase the adjusted R 2. In liver, α-VA concentration explained much of the variation of VA (P < 0.001, R 2 > 0.7), but far less in epididymal and retroperitoneal adipose (P = 0.004 and 0.012, respectively, R 2 < 0.4). CONCLUSIONS: Adipose VA is correlated with liver VA and is a potential biomarker of VA status. It is not fully explained by chylomicron deposition and is negatively affected by serum retinol. Adipose biopsy validation is needed for human applications.
BACKGROUND: Liver vitamin A (VA) concentration is the gold standard for VA status, but is not routinely accessible. Adipose tissue VA concentrations, as retinol and retinyl esters, may be correlated to liver VA. α-VA (as α-retinol) is a cleavage product of α-carotene that traces postprandial VA distribution to tissues but cannot recirculate from hepatic stores, providing insight into tissue VA sources. OBJECTIVE: We performed a secondary analysis of VA and α-VA in Mongolian gerbil liver and adipose to determine the suitability of adipose tissue VA as a biomarker of VA status. METHODS: Gerbils (n = 186) consumed feeds containing 0-15.9 μg (0-55.6 nmol) retinol activity equivalents/g as preformed VA and/or provitamin A carotenoids for 36-62 d in 3 studies. Body fat percentage was determined in the final study by MRI. Serum and liver retinol, α-retinol, and retinyl esters were extracted and analyzed by HPLC or ultra-performance LC (UPLC). Epididymal and retroperitoneal adipose tissue retinol and α-retinol were determined by UPLC after homogenization, saponification, and extraction. Linear regression models with appropriate data transformations identified determinants of adipose VA concentrations. RESULTS: Liver VA did not predict serum retinol concentrations. After logarithmic transformation of adipose and liver values, liver VA positively predicted both adipose depots' VA concentrations (P < 0.001, R 2 > 0.7). Adding serum retinol or body fat percentage did not significantly increase the adjusted R 2. In liver, α-VA concentration explained much of the variation of VA (P < 0.001, R 2 > 0.7), but far less in epididymal and retroperitoneal adipose (P = 0.004 and 0.012, respectively, R 2 < 0.4). CONCLUSIONS: Adipose VA is correlated with liver VA and is a potential biomarker of VA status. It is not fully explained by chylomicron deposition and is negatively affected by serum retinol. Adipose biopsy validation is needed for human applications.
Entities:
Keywords:
adipose tissue; biomarkers; chylomicron remnants; retinol-binding protein; vitamin A
Authors: H K Biesalski; J Frank; S C Beck; F Heinrich; B Illek; R Reifen; H Gollnick; M W Seeliger; B Wissinger; E Zrenner Journal: Am J Clin Nutr Date: 1999-05 Impact factor: 7.045
Authors: L Quadro; W S Blaner; D J Salchow; S Vogel; R Piantedosi; P Gouras; S Freeman; M P Cosma; V Colantuoni; M E Gottesman Journal: EMBO J Date: 1999-09-01 Impact factor: 11.598
Authors: Jennine M Lunetta; Rebecca A Zulim; Stephen R Dueker; Yumei Lin; Vicky Flaig; Philip D Schneider; Bruce M Wolfe; Andrew J Clifford Journal: Anal Biochem Date: 2002-05-01 Impact factor: 3.365
Authors: Margaret Sowa; Luciana Mourao; Jesse Sheftel; Mikayla Kaeppler; Gabrielle Simons; Michael Grahn; Christopher R Davis; Johannes von Lintig; Philipp W Simon; Kevin V Pixley; Sherry A Tanumihardjo Journal: J Nutr Date: 2020-11-19 Impact factor: 4.798